| Literature DB >> 28962631 |
Xusheng Qiu1, Chunchun Meng1, Yuan Zhan1, Shengqing Yu1, Shichao Li1, Tingting Ren1, Weifeng Yuan1, Shuqin Xu1, Yingjie Sun1, Lei Tan1, Cuiping Song1, Ying Liao1, Zhuang Ding2, Xiufan Liu3,4, Chan Ding5,6.
Abstract
BACKGROUND: For many years, ND has been one of the most important infectious pigeon diseases in China. In recent years, a high mortality has been observed in ND-infected pigeons in China. Mortality is from 40% to 80% or 100% in some cases.Entities:
Keywords: Antigenic differences; Newcastle disease virus; Phylogenetic analysis; Pigeon; Virulence
Mesh:
Substances:
Year: 2017 PMID: 28962631 PMCID: PMC5622419 DOI: 10.1186/s12985-017-0857-7
Source DB: PubMed Journal: Virol J ISSN: 1743-422X Impact factor: 4.099
Fig. 1Phylogenetic tree based on full-length nucleotide sequences of NDV strains. The tree of 41 nucleotide sequences was constructed using MEGA7 [33]. Strain genotypes are marked on the right. The GenBank accession numbers of the reference NDV strains are listed in Additional file 2: Table S2. *, the strains investigated in this study
Fig. 2Unrooted maximum likelihood radial phylogram of the isolate genotypes. The tree was constructed on a 374-nt section of the F gene sequences from 360 genotype VI NDV isolates and 24 other genotypes representative strains in GenBank, and relevant evolutionary analyses were conducted in MEGA7 [33]. The tree is to scale, with branch lengths measured in number of substitutions per site. Names of each PPMV-1 strain are not shown but represented by colored symbols. Genotypes and groups of each clade are labeled. All data and accession numbers for reference F gene sequences of the isolates and strains were from EMBL/GenBank based on established phylogenic analysis (Additional file 2: Table S2)
Fig. 3Unrooted maximum likelihood radial phylogram of the subgroup VIb/4bii f. The tree was constructed on a 374-nt section of the F gene sequences from 176 PPMV-1 isolates. Groupings of each clade are labeled
Specific amino acid substitutions in F and HN proteins of endemic PPMV-1 strains in China compared to LaSota. Amino acids that are the same as LaSota are indicated by “-”
| Subgenotype | clade | strains | F protein | HN protein | ||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6 | 8 | 13 | 14 | 16 | 28 | 179 | 203 | 259 | 432 | 506 | 59 | 66 | 74 | 84 | 121 | 145 | 232 | 263 | 309 | 432 | 497 | 569 | ||||
| II | LaSota | S | K | M | M | T | P | V | A | Q | I | V | I | A | L | I | I | A | T | N | D | S | A | D | ||
| VIb/4bii f | Belgium/11-like | pi/SH/CH/0163/2012 | H | R | P | T | I | S | I | S | H | – | I | V | V | I | – | – | I | N | K | – | H | T | E | |
| pi/SH/CH/0167/2013 | H | R | P | T | I | S | I | S | H | – | I | V | V | I | – | – | I | N | K | – | H | T | E | |||
| pi/SH/CH/0168/2013 | H | R | P | T | I | S | I | S | H | – | I | V | V | I | – | – | I | N | K | – | H | T | E | |||
| pi/YN/1111/13 | H | R | P | T | I | S | I | S | H | – | I | V | V | I | – | – | I | N | K | – | H | T | E | |||
| pi/AH/2365/12 | H | R | P | T | I | S | I | S | H | – | I | V | V | I | – | – | I | N | K | – | H | T | E | |||
| Belgium/11–09620/2011 | H | R | L | T | I | S | I | S | H | – | I | V | V | I | – | – | I | N | K | – | H | T | E | |||
| Belgium/11–07574/2011 | H | R | L | T | I | S | I | S | H | – | I | V | V | I | – | – | I | N | K | – | H | – | E | |||
| P4-like | P4 | H | R | L | – | I | L | – | T | H | V | – | – | – | – | V | V | V | – | K | N | Y | – | – | ||
| pi/SD/CH/0132/2012 | H | G | L | – | V | L | – | T | – | V | – | – | – | – | V | V | V | – | R | N | Y | – | – | |||
| JS/07/22/Pi | H | R | L | – | V | L | – | T | – | V | – | – | – | – | V | V | V | – | R | N | Y | – | – | |||
| pi/CH/LHLJ/110822 | H | R | L | – | V | L | – | T | – | V | – | – | – | – | V | V | V | – | R | N | Y | – | – | |||
| pi/CH/LGD/110947 | H | G | P | – | V | L | – | T | – | V | – | – | – | – | V | V | V | – | R | N | Y | – | – | |||
| Belgium/98-like | Belgium/98–238/1998 | Y | R | L | – | I | L | – | T | – | V | – | – | – | – | – | V | I | – | K | N | Y | – | – | ||
| Belgium/98–248/1998 | Y | R | L | – | I | L | – | T | – | V | – | – | – | – | – | V | I | – | K | N | Y | – | – | |||
| Belgium/07–04943/2007 | Y | R | L | – | I | L | – | T | – | V | – | – | – | – | – | V | I | – | K | N | Y | – | – | |||
| VIb/4bii d | Pigeon/China/SD2012 | – | R | P | – | I | – | – | T | H | – | – | – | T | – | – | V | T | – | K | – | Y | – | – | ||
| VIb/4bi | IT-227/82 | – | R | L | T | I | – | – | T | H | – | – | – | T | – | – | V | T | – | K | – | H | – | G | ||
| VIe | US(CA)/1083 Fontana/72 | – | R | L | – | I | L | – | T | – | – | – | – | T | – | – | V | T | – | K | – | Y | – | – | ||
Fig. 4Cross hemagglutination inhibition values for anti-NDV chicken sera (a) and pigeon sera (b) against Lasota, ND167 and ND132. Data are presented as mean ± standard deviation. The statistical differences between each group of values were determined by two-way ANOVA and labeled in the figures. (* P < 0.05; ** P < 0.01; ns, no significant difference)
Cross virus-neutralization titers for anti-NDV sera against LaSota, ND167 and ND132 in embryonated chicken eggs
| Anti-serum | NDV strain | ||
|---|---|---|---|
| La Sota | ND132 | ND167 | |
| Anti-LaSota | 1:288 | 1:102 | 1:94 |
| Anti-ND132 | 1:150 | 1:256 | 1:161 |
| Anti-ND167 | 1:25 | 1:51 | 1:189 |
Pathogenicity indexes for PPMV-1 isolates in this study
| Strain | HA titer | MDT | ICPI |
|---|---|---|---|
| ND132 | 26 | 66 h | 0.95 |
| ND163 | 27 | 62 h | 1.15 |
| ND167 | 27 | 60 h | 1.21 |
| ND168 | 27 | 65 h | 1.18 |
Viral shedding of PPMV-1 from the oral cavity and cloaca of experimentally infected pigeons. Pigeons in groups A1, A2 and A3 were infected with 106 EID50pi/China/SD/2012/132; pigeons in groups B1, B2 and B3 were infected with 106 EID50 pi/China/SH/2013/167. Positive-control group (PC) birds were intramuscularly injected with 106 EID50 F48E8; and negative-control group (NC) birds were inoculated with sterile PBS (pH 7.2). IV, intravenous injection; IM, intramuscular injection; IN, intranasal infection; IO, intraocular infection
| Group | A1 | A2 | A3 | B1 | B2 | B3 | PC | NC | |
|---|---|---|---|---|---|---|---|---|---|
| dpi | IV | IM | IN&IO | IV | IM | IN&IO | IM | IM | |
| 5 | Oropharyngeal | 0/7 | 0/7 | 2/7 | 2/7 | 1/7 | 2/7 | 2/6 | 0/7 |
| Cloacal | 0/7 | 0/7 | 0/7 | 1/7 | 0/7 | 0/7 | 0/6 | 0/7 | |
| 7 | Oropharyngeal | 3/7 | 1/7 | 2/7 | 3/7 | 6/7 | 1/7 | 6/6 | 0/7 |
| Cloacal | 0/7 | 0/7 | 0/7 | 1/7 | 0/7 | 1/7 | 2/6 | 0/7 | |
| 10 | Oropharyngeal | 3/7 | 4/7 | 0/7 | 1/7 | 3/7 | 1/7 | 3/4 | 0/7 |
| Cloacal | 7/7 | 6/7 | 1/7 | 6/7 | 7/7 | 1/7 | 1/4 | 0/7 | |
| 14 | Oropharyngeal | 0/7 | 0/7 | 0/7 | 1/7 | 0/7 | 0/7 | 1/4 | 0/7 |
| Cloacal | 1/7 | 1/7 | 0/7 | 2/7 | 1/7 | 1/7 | 1/4 | 0/7 | |
| 21 | Oropharyngeal | 0/7 | 0/7 | 1/7 | 0/7 | 0/7 | 0/7 | 0/4 | 0/7 |
| Cloacal | 1/7 | 0/7 | 0/7 | 0/7 | 0/7 | 0/7 | 0/4 | 0/7 | |
| 28 | Oropharyngeal | 0/7 | 0/7 | 0/7 | 0/7 | 0/7 | 0/7 | 0/4 | 0/7 |
| Cloacal | 0/7 | 0/7 | 0/7 | 0/7 | 0/7 | 0/7 | 0/4 | 0/7 | |
| 35 | Oropharyngeal | 0/7 | 0/7 | 0/7 | 0/7 | 0/7 | 0/7 | 0/4 | 0/7 |
| Cloacal | 0/7 | 0/7 | 0/7 | 0/7 | 0/7 | 0/7 | 0/4 | 0/7 | |
| 42 | Oropharyngeal | 0/7 | 0/7 | 0/7 | 0/7 | 0/7 | 0/7 | 0/4 | 0/7 |
| Cloacal | 0/7 | 0/7 | 0/7 | 0/7 | 0/7 | 0/7 | 0/4 | 0/7 | |